Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.

2.

New study links air pollution with higher rates of head and neck cancer

3.

Targeted radiation therapy shows near-complete response in rare sarcoma patients

4.

An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.

5.

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot